GLPwatch
Papers (10409)
Page 130 of 174, ranked by citation count.
- Advantage of Semaglutide: Comprehensive Analysis of Metabolic Impact of Semaglutide-Treated and Pair-Fed Rats.
- Dissecting Hidden Liraglutide Oligomerization Pathways via Direct Mass Technology, Electron-Capture Dissociation, and Molecular Dynamics.
- Evaluating Suicidal Risk in GLP-1RA Therapy: An Umbrella Review of Meta-Analytic Evidence.
- Therapeutic Effects and Mechanism of Liraglutide in Rats with Type 2 Diabetes and Metabolic-associated Fatty Liver Disease.
- Temporal and subgroup disparities in mediation effects on cardiovascular outcomes with liraglutide and semaglutide: a post-hoc analysis of LEADER and SUSTAIN-6 trials.
- Case report: Tirzepatide for mitochondrial diabetes mellitus with a mutation at position 3271 and transient GAD antibody positivity.
- Evaluation of A Novel GLP-1R Ligand for PET Imaging of Prostate Cancer.
- Association of tirzepatide with cardiometabolic benefits in Chinese adults: post hoc subgroup analysis of SURMOUNT-CN study.
- Differential Treatment Effects on β-Cell Function Using Model-Based Parameters in Type 2 Diabetes: Results From the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).
- Exenatide in type 2 diabetes.
- Reduced 90-Day Cardiovascular and Infectious Complications After Open Reduction Internal Fixation of Ankle Fractures in Type II Diabetic Patients Using Semaglutide Preoperatively.
- Diagnosis and management of hyperglycaemia in patients treated with antipsychotic drugs.
- Mexican population sub-analysis of the lixilan clinical program with the fixed ratio combination of insulin glargine and lixisenatide (iGlarLixi).
- Pharmacokinetics and Tolerability of Exenatide Delivered by 7-Day Continuous Subcutaneous Infusion in Healthy Volunteers.
- Dulaglutide use to improve binge eating behaviors in a person with type 2 diabetes and obesity.
- Effectiveness and adherence in a tirzepatide-supported digital weight-loss programme in Australia: A real-world observational study.
- Sustained Islet Allograft Function After Peritransplant Treatment Using Exenatide With and Without Everolimus.
- The Use of Exenatide in Managing Markers of Cardiovascular Risk in Patients with Type 2 Diabetes: A Systematic Review.
- Effect of Exenatide Therapy on Platelet Function in Type 2 Diabetes Mellitus.
- Comparative efficacy of tirzepatide and glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes: a systematic review and network meta-analysis.
- Structural stability-chromatographic retention relationship on exenatide diastereomer separation.
- Impact of baseline characteristics on the efficacy of once-weekly subcutaneous semaglutide among participants with type 2 diabetes: A post hoc analysis of SUSTAIN China.
- Proteomic effects of short-term liraglutide vs. placebo in a blinded crossover RCT: Implications for efficacy, safety, and comparison with semaglutide.
- GLP1 receptor agonism alters growth and therapeutic response in prostate cancer.
- ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide.
- Taking back control: The experience of adults using semaglutide and tirzepatide for obesity treatment - A qualitative study.
- Initial Exploration of the In Vitro Activation of GLP-1 and GIP Receptors and Pancreatic Islet Cell Protection by Salmon-Derived Bioactive Peptides.
- Real-world effectiveness of GLP-1 receptor agonist-based treatment strategies on "time in range" in patients with type 2 diabetes.
- The effects of liraglutide on expressions of insulin secretion and beta cell survive associated GPCR genes in pancreatic beta cells.
- Counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes treated with tirzepatide.
- Integrating Drug Target Information in Deep Learning Models to Predict the Risk of Adverse Events in Patients with Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder.
- Exacerbation of Postural Orthostatic Tachycardia Syndrome With Tirzepatide Prescribed for Weight Loss.
- Protocol for Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetes Cases (The MAG1C trial): a randomised, double-blinded, placebo-controlled trial.
- Incretin-induced changes in the transcriptome of skeletal muscles of fa/fa Zucker rat (ZFR) with obesity, without diabetes.
- Semaglutide Versus Dulaglutide and Liraglutide in Chinese Patients With T2DM: A Multicenter Real-World Study.
- Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide.
- Rational design and evaluation of GLP-1 derivative for treating hyperglycemia combined with overexercise-induced myocardial injury.
- Glucagon-like peptide-1 receptor agonists and hair loss: An emerging clinical concern.
- Assessing the shadows: A meta-analysis of GLP-1 agonists and suicidal ideation.
- RISING STARS: Effects of a GLP-1 receptor polymorphism on responses to liraglutide.
- Computational modelling the impact of GLP-1 receptor agonists on botulinum toxin A: Evidence for reduced treatment durability across neurologic and aesthetic indications.
- Insulins for type 2 diabetes.
- Semaglutide: FDA publishes warning amid reports of patients overdosing.
- Acute Functional Gastric Outlet Obstruction Associated With Low-Dose Tirzepatide.
- [Cutting-edge of medicine; the prospects of novel anti-obesity drugs].
- RYGB induces vagal sensory neuropathy characterized by altered Glp1r expression and enhanced exendin-4 responsiveness in male mice.
- Design of potent and proteolytically stable double biaryl-stapled GLP-1R/GIPR peptide dual agonists.
- Exenatide extended-release: a once-weekly option for patients with type 2 diabetes.
- Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide.
- The Impact of Liraglutide on Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.
- Semaglutide may provide sustained weight loss for at least four years, study reports.
- GLP-1 receptor agonist exenatide uncouples food intake from hedonic and anticipatory regulation in non-human primates: insights from an operant meal schedule paradigm.
- Oral semaglutide: an innovative paradigm in the management of cardiovascular risk in patients with Type 2 diabetes.
- Glucagon-like peptide-1 receptor PET/CT with <sup>68</sup>Ga-exendin-4 for localizing insulinoma: a real-world, single-center study.
- Lixisenatide in early parkinson's disease: efficacy, safety, and future directions: a correspondence.
- Efficacy of liraglutide as a follow-up therapy after resolution of glucotoxicity with intensive insulin therapy.
- GLP-1R Agonists for Weight Loss in Psychiatric Disorders: A Systematic Review and Meta-analysis.
- Clinical efficacy of GLP-1 agonists and their place in the diabetes treatment algorithm.
- At ObesityWeek, More Data and Questions About Semaglutide, Tirzepatide, and Retatrutide.
- Glucagon-like peptide-1 receptor agonists and Wernicke encephalopathy: A pharmacovigilance study and literature review.